Loading...
Efficacy and safety of adalimumab in hidradenitis suppurativa: A systematic review and meta-analysis of randomized controlled trials
BACKGROUND: Adalimumab is used as a first-line biologic agent in the management of moderate-to-severe hidradenitis suppurativa (HS). The objective of the present study was to evaluate the efficacy and safety of adalimumab in patients with moderate-to-severe HS. METHODS: We performed a systematic rev...
Saved in:
| Published in: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Lippincott Williams & Wilkins
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8183777/ https://ncbi.nlm.nih.gov/pubmed/34087885 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000026190 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|